- Home
- ZIMV vs NHS Comparison
ZIMV vs NHS Comparison
Compare ZIMV & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- NHS
- Stock Information
- Founded
- ZIMV 2021
- NHS 2003
- Country
- ZIMV United States
- NHS United States
- Employees
- ZIMV N/A
- NHS N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NHS Trusts Except Educational Religious and Charitable
- Sector
- ZIMV Health Care
- NHS Finance
- Exchange
- ZIMV Nasdaq
- NHS Nasdaq
- Market Cap
- ZIMV 262.9M
- NHS 221.6M
- IPO Year
- ZIMV N/A
- NHS N/A
- Fundamental
- Price
- ZIMV $9.23
- NHS $7.54
- Analyst Decision
- ZIMV Hold
- NHS
- Analyst Count
- ZIMV 2
- NHS 0
- Target Price
- ZIMV $10.00
- NHS N/A
- AVG Volume (30 Days)
- ZIMV 129.0K
- NHS 111.8K
- Earning Date
- ZIMV 07-31-2025
- NHS 01-01-0001
- Dividend Yield
- ZIMV N/A
- NHS 13.44%
- EPS Growth
- ZIMV N/A
- NHS N/A
- EPS
- ZIMV N/A
- NHS N/A
- Revenue
- ZIMV $443,551,000.00
- NHS N/A
- Revenue This Year
- ZIMV $1.96
- NHS N/A
- Revenue Next Year
- ZIMV $1.95
- NHS N/A
- P/E Ratio
- ZIMV N/A
- NHS N/A
- Revenue Growth
- ZIMV N/A
- NHS N/A
- 52 Week Low
- ZIMV $8.15
- NHS $6.95
- 52 Week High
- ZIMV $22.40
- NHS $9.17
- Technical
- Relative Strength Index (RSI)
- ZIMV 49.25
- NHS 44.95
- Support Level
- ZIMV $8.39
- NHS $7.37
- Resistance Level
- ZIMV $9.08
- NHS $7.51
- Average True Range (ATR)
- ZIMV 0.26
- NHS 0.07
- MACD
- ZIMV -0.01
- NHS -0.02
- Stochastic Oscillator
- ZIMV 49.40
- NHS 26.47
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.